Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Antibiotic Drug Use and the Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Population-Based Case-Control Study
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4493297
Author(s) Frey, Noel; Bircher, Andreas; Bodmer, Michael; Jick, Susan S.; Meier, Christoph R.; Spoendlin, Julia
Author(s) at UniBasel Meier, Christoph R.
Year 2018
Title Antibiotic Drug Use and the Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Population-Based Case-Control Study
Journal Journal of Investigative Dermatology
Volume 138
Number 5
Pages / Article-Number 1207-1209
Mesh terms Anti-Bacterial Agents, adverse effects; Case-Control Studies; Humans; Risk; Stevens-Johnson Syndrome, etiology; Sulfonamides, adverse effects
Abstract Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare, life-threatening mucocutaneous adverse drug reactions. Sulphonamide antibiotics are commonly accepted as one of the primary causes of SJS/TEN. This notion is based on results from two hospital-based case-control studies that identified the combined antibiotic cotrimoxazole (sulfamethoxazole and trimethoprim) as the cause of several SJS/TEN cases. Associations were also reported for penicillins, quinolones, cephalosporins, macrolides, tetracyclines, and metronidazole. Using data from the UK-based Clinical Practice Research Datalink, we conducted a 1:4-matched case-control study including 480 previously validated SJS/TEN cases (1995-2013) to quantify the association between SJS/TEN and antibiotics. We further quantified absolute risks of SJS/TEN within separate cohorts of antibiotic users and assessed causality in each exposed case using an adapted version of the algorithm of drug causality in epidermal necrolysis (ALDEN). We observed a strong association between SJS/TEN and trimethoprim alone (odds ratio=9.44, 95% CI 3.83-23.25; absolute risk: 0.98 cases/100'000 users), which suggests that the previously reported association between cotrimoxazole and SJS/TEN is at least partly attributable to the non-sulphonamide antibiotic trimethoprim, which is frequently prescribed as a single agent in the UK. Our study further corroborates previously reported associations between SJS/TEN and use of penicillins, quinolones, cephalosporins, and macrolides.
Publisher Elsevier
ISSN/ISBN 0022-202X ; 1523-1747
edoc-URL https://edoc.unibas.ch/68003/
Full Text on edoc No
Digital Object Identifier DOI 10.1016/j.jid.2017.12.015
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/29273314
ISI-Number WOS:000430533700041
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.326 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
20/04/2024